Baillie Gifford — VRTX Trade History
Quarter-by-quarter changes in the Vertex Pharmaceuticals Inc position · CUSIP 92532F100
Currently held · 2.3 YearsFirst seen: 2016 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-06 | Add | 272,561 | 73,140 | +36.7% | $135.4M | 0.12% |
| 2026 Q1 | 2026-05-08 | Reduce | 199,421 | -1,667 | -0.8% | $89.0M | 0.09% |
| 2025 Q4 | 2026-01-23 | Reduce | 201,088 | -5,968 | -2.9% | $91.2M | 0.08% |
| 2025 Q3 | 2025-10-31 | Reduce | 207,056 | -5,423 | -2.6% | $81.1M | 0.06% |
| 2025 Q2 | 2025-08-06 | Add | 212,479 | 78,014 | +58.0% | $94.6M | 0.07% |
| 2025 Q1 | 2025-05-07 | Reduce | 134,465 | -15,373 | -10.3% | $65.2M | 0.06% |
| 2024 Q4 | 2025-01-31 | Add | 149,838 | 9,258 | +6.6% | $60.3M | 0.05% |
| 2024 Q3 | 2024-11-05 | Reduce | 140,580 | -27,036 | -16.1% | $65.4M | 0.05% |
| 2024 Q2 | 2024-07-25 | New | 167,616 | 167,616 | — | $78.6M | 0.06% |
| 2024 Q1 | 2024-05-01 | — | — | — | — | — | — |
| 2023 Q4 | 2024-01-26 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-13 | — | — | — | — | — | — |
| 2023 Q2 | 2023-07-28 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-03 | — | — | — | — | — | — |
| 2022 Q4 | 2023-03-10 | — | — | — | — | — | — |
| 2022 Q3 | 2022-10-27 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-08 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-05 | — | — | — | — | — | — |
| 2021 Q4 | 2022-01-20 | — | — | — | — | — | — |
| 2021 Q3 | 2021-10-19 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-02 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-06 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-10 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-12 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-08 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-10 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-07 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-08 | Sold out | — | -424,845 | -100.0% | — | — |
| 2019 Q1 | 2019-05-01 | Reduce | 424,845 | -302,317 | -41.6% | $78.2M | 0.09% |
| 2018 Q4 | 2019-02-14 | Add | 727,162 | 132,435 | +22.3% | $120.5M | 0.16% |
| 2018 Q3 | 2018-11-13 | Add | 594,727 | 16,288 | +2.8% | $114.6M | 0.12% |
| 2018 Q2 | 2018-07-17 | Add | 578,439 | 31,744 | +5.8% | $98.3M | 0.11% |
| 2018 Q1 | 2018-05-10 | Add | 546,695 | 48,317 | +9.7% | $89.1M | 0.10% |
| 2017 Q4 | 2018-02-13 | Add | 498,378 | 6,547 | +1.3% | $74.7M | 0.09% |
| 2017 Q3 | 2017-10-20 | Add | 491,831 | 6,234 | +1.3% | $74.8M | 0.10% |
| 2017 Q2 | 2017-08-10 | Add | 485,597 | 31,483 | +6.9% | $62.6M | 0.08% |
| 2017 Q1 | 2017-05-12 | Reduce | 454,114 | -6,349 | -1.4% | $49.7M | 0.07% |
| 2016 Q4 | 2017-02-14 | New | 460,463 | 460,463 | — | $33.9M | 0.06% |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.